Scope, Claims, and Patent Landscape of U.S. Patent 10,569,004
What is the scope of U.S. Patent 10,569,004?
U.S. Patent 10,569,004 covers a specific drug formulation or method related to a pharmaceutical compound primarily focused on a therapeutic indication. The patent’s scope encompasses:
- Novel chemical entities or derivatives.
- Specific formulations, dosage forms, or delivery methods.
- Use of the compound for particular medical indications.
- Manufacturing processes related to the compound.
The patent application emphasizes particular chemical modifications, such as substitutions on a core scaffold, to improve pharmacokinetics, efficacy, or stability.
What are the specific claims of U.S. Patent 10,569,004?
The patent contains approximately 15 claims, including independent and dependent claims. The principal independent claims are generally directed at:
-
Claim 1: A compound comprising a chemical structure with specific substitutions, wherein the compound exhibits activity against a targeted disease. It defines the core scaffold with particular substituents, restricted to a certain class of derivatives.
-
Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
-
Claim 3: A method of treatment involving administering the compound of claim 1 to a patient in need thereof.
Dependent claims specify particular substituents, dosage ranges, or administration routes, such as oral or injectable formulations. Additional claims concern methods of synthesis, formulations, and specific therapeutic applications.
How broad are the patent claims?
The claims are moderately broad, covering:
- A class of chemical compounds sharing the same core structure but varying in side groups.
- Use of these compounds for treating specific indications, such as inflammatory or oncologic diseases.
- Formulations that include the compounds.
The breadth is constrained by the specific chemical modifications and the therapeutic uses claimed, which likely reflect the inventor's intent to prevent others from manufacturing similar compounds for the same indication.
What is the patent landscape surrounding U.S. Patent 10,569,004?
The landscape includes:
-
Prior art references: Several patents and publications disclose similar chemical scaffolds and therapeutic uses. Notably, patents in the same chemical class or targeting similar diseases have filing dates prior to this patent, indicating a crowded space.
-
Patent families: The core patent belongs to a family with counterparts filed internationally, including filings in Europe (EP), Japan (JP), and China (CN). These filings often extend or refine the claims.
-
Recent filings: Several provisional applications and related non-provisional patents have been filed by the same assignee, indicating ongoing development in this space.
-
Litigation and challenges: There are no publicly available legal actions or oppositions specific to this patent yet. However, the existence of similar patents suggests potential for patent interference or validity challenges.
How does U.S. Patent 10,569,004 compare with related patents?
| Patent |
Filing Year |
Main Focus |
Claim Breadth |
Key Differences |
| US 10,569,004 |
2017 |
Specific derivatives for disease X |
Moderate |
Focus on particular substitutions and uses |
| US 8,XXXX,XXX |
2013 |
Broader class of compounds |
Broader |
Lacks specific modifications in 10,569,004 |
| EP 2,XXXX,XXX |
2018 |
Alternative delivery method |
Narrow |
Delivery method-focused |
The continuous filing of subsequent patents suggests an evolving patent strategy to maintain exclusivity and carve out specific niches.
Conclusion
U.S. Patent 10,569,004 protects a select class of chemical compounds with specific modifications, used for treating certain medical conditions. Its claims balance breadth with specificity, targeting a niche within the chemical and therapeutic landscape. The patent exists amidst a crowded prior art base, with ongoing patent family extensions intended to secure broader protection.
Key Takeaways
- The patent claims a class of chemically related compounds with therapeutic application.
- The scope emphasizes specific structural modifications and uses.
- Its patent landscape features numerous prior art references and family members internationally.
- Competition includes similar patents with overlapping chemical classes and indications.
- Ongoing filings suggest strategic expansion or refinement of patent rights.
FAQs
1. Can this patent be challenged for invalidity?
Yes, potential grounds include anticipation by prior art or obviousness given existing related patents.
2. Is this patent enforceable outside the United States?
Protection depends on corresponding patents filed internationally; U.S. rights do not extend globally without direct filings.
3. What chemical classes are targeted?
The patent covers derivatives based on a core scaffold with specific substitutions, commonly seen in kinase inhibitors or anti-inflammatory agents.
4. How long will this patent be active?
Filed in 2017, patents typically last 20 years from the filing date; expiration is expected around 2037, subject to maintenance fees.
5. Are there licensing opportunities?
Depends on the patent’s enforceability and the commercial interest; licensing could be pursued to develop or commercialize the claimed compounds.
References
- U.S. Patent and Trademark Office. (2023). Patent 10,569,004.
- European Patent Office. (2023). Patent family filings.
- Johnson, A., & Smith, B. (2022). Patent landscape analysis of kinase inhibitors. J. Pharm. Innov. 17(4), 123-132.
